abstract |
The invention provides methods of treating solid tumors with a combination of tucatinib, or salt or solvate thereof, and an anti-PD-1 antibody, or an antigen-binding fragment thereof. The invention also provides methods of treating solid tumors with a combination of tucatinib, or salt or solvate thereof, and an anti-PD-L1 antibody, or an antigen-binding fragment thereof. |